nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—HTR2B—Cyproheptadine—allergic rhinitis	0.0756	0.117	CbGbCtD
Sorafenib—HTR2C—Cyproheptadine—allergic rhinitis	0.0492	0.076	CbGbCtD
Sorafenib—CYP2C19—Desloratadine—allergic rhinitis	0.0256	0.0396	CbGbCtD
Sorafenib—CYP1A2—Desloratadine—allergic rhinitis	0.0236	0.0365	CbGbCtD
Sorafenib—CYP2B6—Diphenhydramine—allergic rhinitis	0.0231	0.0358	CbGbCtD
Sorafenib—CYP2C9—Desloratadine—allergic rhinitis	0.0213	0.0329	CbGbCtD
Sorafenib—ABCB1—Desloratadine—allergic rhinitis	0.0206	0.0319	CbGbCtD
Sorafenib—CYP2D6—Desloratadine—allergic rhinitis	0.0195	0.0301	CbGbCtD
Sorafenib—ABCG2—Hydrocortisone—allergic rhinitis	0.0183	0.0283	CbGbCtD
Sorafenib—CYP2C8—Loratadine—allergic rhinitis	0.0175	0.0271	CbGbCtD
Sorafenib—CYP2C8—Montelukast—allergic rhinitis	0.0175	0.0271	CbGbCtD
Sorafenib—CYP2C19—Loratadine—allergic rhinitis	0.0147	0.0227	CbGbCtD
Sorafenib—CYP2C19—Diphenhydramine—allergic rhinitis	0.0147	0.0227	CbGbCtD
Sorafenib—CYP1A2—Diphenhydramine—allergic rhinitis	0.0136	0.021	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Hydrocortisone—allergic rhinitis	0.0135	0.0209	CbGbCtD
Sorafenib—CYP3A7—Hydrocortisone—allergic rhinitis	0.0135	0.0209	CbGbCtD
Sorafenib—ABCC2—Dexamethasone—allergic rhinitis	0.0126	0.0195	CbGbCtD
Sorafenib—CYP3A4—Flunisolide—allergic rhinitis	0.0124	0.0191	CbGbCtD
Sorafenib—CYP2C9—Montelukast—allergic rhinitis	0.0122	0.0189	CbGbCtD
Sorafenib—CYP2C9—Loratadine—allergic rhinitis	0.0122	0.0189	CbGbCtD
Sorafenib—CYP2C9—Diphenhydramine—allergic rhinitis	0.0122	0.0189	CbGbCtD
Sorafenib—ABCB1—Loratadine—allergic rhinitis	0.0119	0.0183	CbGbCtD
Sorafenib—CYP3A4—Olopatadine—allergic rhinitis	0.0116	0.018	CbGbCtD
Sorafenib—ABCG2—Dexamethasone—allergic rhinitis	0.0114	0.0176	CbGbCtD
Sorafenib—CYP2D6—Loratadine—allergic rhinitis	0.0112	0.0173	CbGbCtD
Sorafenib—CYP2D6—Diphenhydramine—allergic rhinitis	0.0112	0.0173	CbGbCtD
Sorafenib—ABCB1—Methylprednisolone—allergic rhinitis	0.0108	0.0168	CbGbCtD
Sorafenib—CYP3A5—Hydrocortisone—allergic rhinitis	0.0101	0.0157	CbGbCtD
Sorafenib—CYP2C8—Hydrocortisone—allergic rhinitis	0.00974	0.0151	CbGbCtD
Sorafenib—CYP3A7—Dexamethasone—allergic rhinitis	0.0084	0.013	CbGbCtD
Sorafenib—CYP3A7-CYP3A51P—Dexamethasone—allergic rhinitis	0.0084	0.013	CbGbCtD
Sorafenib—CYP2B6—Dexamethasone—allergic rhinitis	0.008	0.0124	CbGbCtD
Sorafenib—CYP3A4—Montelukast—allergic rhinitis	0.0071	0.011	CbGbCtD
Sorafenib—CYP3A4—Loratadine—allergic rhinitis	0.0071	0.011	CbGbCtD
Sorafenib—ABCB1—Betamethasone—allergic rhinitis	0.00705	0.0109	CbGbCtD
Sorafenib—ABCB1—Prednisolone—allergic rhinitis	0.00696	0.0108	CbGbCtD
Sorafenib—ABCB1—Hydrocortisone—allergic rhinitis	0.0066	0.0102	CbGbCtD
Sorafenib—CYP3A4—Methylprednisolone—allergic rhinitis	0.0065	0.01	CbGbCtD
Sorafenib—CYP3A5—Dexamethasone—allergic rhinitis	0.0063	0.00974	CbGbCtD
Sorafenib—CYP2C8—Dexamethasone—allergic rhinitis	0.00606	0.00937	CbGbCtD
Sorafenib—CYP2C19—Dexamethasone—allergic rhinitis	0.00508	0.00786	CbGbCtD
Sorafenib—RET—autonomic nervous system—allergic rhinitis	0.00494	0.0472	CbGeAlD
Sorafenib—CYP3A4—Triamcinolone—allergic rhinitis	0.00492	0.00761	CbGbCtD
Sorafenib—CYP2C9—Dexamethasone—allergic rhinitis	0.00423	0.00653	CbGbCtD
Sorafenib—CYP3A4—Betamethasone—allergic rhinitis	0.00423	0.00653	CbGbCtD
Sorafenib—CYP3A4—Prednisolone—allergic rhinitis	0.00417	0.00644	CbGbCtD
Sorafenib—ABCB1—Dexamethasone—allergic rhinitis	0.0041	0.00634	CbGbCtD
Sorafenib—CYP3A4—Hydrocortisone—allergic rhinitis	0.00395	0.00611	CbGbCtD
Sorafenib—CYP2D6—Dexamethasone—allergic rhinitis	0.00387	0.00597	CbGbCtD
Sorafenib—MAPK15—bronchus—allergic rhinitis	0.00311	0.0297	CbGeAlD
Sorafenib—CYP3A4—Dexamethasone—allergic rhinitis	0.00246	0.0038	CbGbCtD
Sorafenib—CDK7—respiratory system—allergic rhinitis	0.0022	0.0211	CbGeAlD
Sorafenib—ZAK—respiratory system—allergic rhinitis	0.0019	0.0182	CbGeAlD
Sorafenib—MAP3K19—respiratory system—allergic rhinitis	0.00182	0.0175	CbGeAlD
Sorafenib—TIE1—respiratory system—allergic rhinitis	0.00174	0.0166	CbGeAlD
Sorafenib—ZAK—eye—allergic rhinitis	0.00174	0.0166	CbGeAlD
Sorafenib—KIT—exocrine gland—allergic rhinitis	0.00161	0.0154	CbGeAlD
Sorafenib—FLT3—respiratory system—allergic rhinitis	0.00158	0.0151	CbGeAlD
Sorafenib—ZAK—bronchus—allergic rhinitis	0.00157	0.015	CbGeAlD
Sorafenib—HIPK3—bronchus—allergic rhinitis	0.00153	0.0147	CbGeAlD
Sorafenib—EPHX2—eye—allergic rhinitis	0.00146	0.0139	CbGeAlD
Sorafenib—TIE1—epithelium—allergic rhinitis	0.00145	0.0139	CbGeAlD
Sorafenib—FLT4—respiratory system—allergic rhinitis	0.00144	0.0138	CbGeAlD
Sorafenib—FLT4—eye—allergic rhinitis	0.00131	0.0126	CbGeAlD
Sorafenib—MKNK2—respiratory system—allergic rhinitis	0.0013	0.0125	CbGeAlD
Sorafenib—FLT4—epithelium—allergic rhinitis	0.0012	0.0115	CbGeAlD
Sorafenib—MKNK2—eye—allergic rhinitis	0.00119	0.0114	CbGeAlD
Sorafenib—RALBP1—respiratory system—allergic rhinitis	0.00118	0.0112	CbGeAlD
Sorafenib—MKNK1—eye—allergic rhinitis	0.00117	0.0112	CbGeAlD
Sorafenib—CDK7—lung—allergic rhinitis	0.00117	0.0112	CbGeAlD
Sorafenib—FGFR1—bronchus—allergic rhinitis	0.00117	0.0112	CbGeAlD
Sorafenib—TAOK2—lung—allergic rhinitis	0.00116	0.0111	CbGeAlD
Sorafenib—FLT1—respiratory system—allergic rhinitis	0.00112	0.0107	CbGeAlD
Sorafenib—RAF1—respiratory system—allergic rhinitis	0.00111	0.0106	CbGeAlD
Sorafenib—MAP3K7—bronchus—allergic rhinitis	0.00111	0.0106	CbGeAlD
Sorafenib—MKNK2—epithelium—allergic rhinitis	0.00109	0.0104	CbGeAlD
Sorafenib—RALBP1—eye—allergic rhinitis	0.00107	0.0103	CbGeAlD
Sorafenib—MKNK2—bronchus—allergic rhinitis	0.00107	0.0102	CbGeAlD
Sorafenib—RET—epithelium—allergic rhinitis	0.00106	0.0102	CbGeAlD
Sorafenib—STK10—respiratory system—allergic rhinitis	0.00106	0.0101	CbGeAlD
Sorafenib—MKNK1—bronchus—allergic rhinitis	0.00106	0.0101	CbGeAlD
Sorafenib—PDGFRA—respiratory system—allergic rhinitis	0.00105	0.01	CbGeAlD
Sorafenib—FLT1—eye—allergic rhinitis	0.00102	0.00977	CbGeAlD
Sorafenib—RAF1—eye—allergic rhinitis	0.00102	0.00972	CbGeAlD
Sorafenib—ZAK—lung—allergic rhinitis	0.00101	0.00967	CbGeAlD
Sorafenib—MAP3K7—trachea—allergic rhinitis	0.000993	0.0095	CbGeAlD
Sorafenib—HIPK3—lung—allergic rhinitis	0.000989	0.00946	CbGeAlD
Sorafenib—MAP3K19—lung—allergic rhinitis	0.000969	0.00927	CbGeAlD
Sorafenib—RALBP1—bronchus—allergic rhinitis	0.000968	0.00926	CbGeAlD
Sorafenib—MKNK2—trachea—allergic rhinitis	0.000962	0.0092	CbGeAlD
Sorafenib—KDR—respiratory system—allergic rhinitis	0.000945	0.00904	CbGeAlD
Sorafenib—FLT1—epithelium—allergic rhinitis	0.000935	0.00894	CbGeAlD
Sorafenib—RAF1—epithelium—allergic rhinitis	0.000929	0.00889	CbGeAlD
Sorafenib—TIE1—lung—allergic rhinitis	0.000924	0.00884	CbGeAlD
Sorafenib—CSF1R—respiratory system—allergic rhinitis	0.000923	0.00882	CbGeAlD
Sorafenib—FLT1—bronchus—allergic rhinitis	0.00092	0.0088	CbGeAlD
Sorafenib—RAF1—bronchus—allergic rhinitis	0.000915	0.00875	CbGeAlD
Sorafenib—EPHB6—bronchus—allergic rhinitis	0.00091	0.0087	CbGeAlD
Sorafenib—BRAF—lung—allergic rhinitis	0.000886	0.00848	CbGeAlD
Sorafenib—RAF1—skin of body—allergic rhinitis	0.000884	0.00845	CbGeAlD
Sorafenib—EPHB6—skin of body—allergic rhinitis	0.000879	0.0084	CbGeAlD
Sorafenib—STK10—bronchus—allergic rhinitis	0.000871	0.00833	CbGeAlD
Sorafenib—RALBP1—trachea—allergic rhinitis	0.000869	0.00831	CbGeAlD
Sorafenib—KDR—eye—allergic rhinitis	0.000864	0.00826	CbGeAlD
Sorafenib—EPHX2—lung—allergic rhinitis	0.000847	0.0081	CbGeAlD
Sorafenib—CSF1R—eye—allergic rhinitis	0.000843	0.00806	CbGeAlD
Sorafenib—FLT3—lung—allergic rhinitis	0.000841	0.00804	CbGeAlD
Sorafenib—KIT—respiratory system—allergic rhinitis	0.000838	0.00801	CbGeAlD
Sorafenib—FLT1—trachea—allergic rhinitis	0.000826	0.00791	CbGeAlD
Sorafenib—RAF1—trachea—allergic rhinitis	0.000822	0.00786	CbGeAlD
Sorafenib—PDGFRB—respiratory system—allergic rhinitis	0.000818	0.00783	CbGeAlD
Sorafenib—EPHB6—trachea—allergic rhinitis	0.000817	0.00781	CbGeAlD
Sorafenib—KDR—epithelium—allergic rhinitis	0.00079	0.00756	CbGeAlD
Sorafenib—MAP2K5—bronchus—allergic rhinitis	0.000778	0.00744	CbGeAlD
Sorafenib—KDR—bronchus—allergic rhinitis	0.000778	0.00744	CbGeAlD
Sorafenib—PDGFRA—trachea—allergic rhinitis	0.000774	0.00741	CbGeAlD
Sorafenib—FLT4—lung—allergic rhinitis	0.000764	0.00731	CbGeAlD
Sorafenib—CSF1R—bronchus—allergic rhinitis	0.000759	0.00726	CbGeAlD
Sorafenib—FGFR1—lung—allergic rhinitis	0.000753	0.00721	CbGeAlD
Sorafenib—PDGFRB—eye—allergic rhinitis	0.000748	0.00715	CbGeAlD
Sorafenib—CSF1R—skin of body—allergic rhinitis	0.000733	0.00701	CbGeAlD
Sorafenib—MAP3K7—lung—allergic rhinitis	0.000713	0.00682	CbGeAlD
Sorafenib—KIT—epithelium—allergic rhinitis	0.0007	0.0067	CbGeAlD
Sorafenib—MAP2K5—trachea—allergic rhinitis	0.000699	0.00668	CbGeAlD
Sorafenib—KDR—trachea—allergic rhinitis	0.000699	0.00668	CbGeAlD
Sorafenib—MKNK2—lung—allergic rhinitis	0.000691	0.00661	CbGeAlD
Sorafenib—KIT—bronchus—allergic rhinitis	0.00069	0.0066	CbGeAlD
Sorafenib—PDGFRB—epithelium—allergic rhinitis	0.000684	0.00654	CbGeAlD
Sorafenib—MKNK1—lung—allergic rhinitis	0.000683	0.00653	CbGeAlD
Sorafenib—CSF1R—trachea—allergic rhinitis	0.000682	0.00652	CbGeAlD
Sorafenib—PDGFRB—bronchus—allergic rhinitis	0.000673	0.00644	CbGeAlD
Sorafenib—KIT—skin of body—allergic rhinitis	0.000666	0.00637	CbGeAlD
Sorafenib—PDGFRB—skin of body—allergic rhinitis	0.00065	0.00622	CbGeAlD
Sorafenib—RALBP1—lung—allergic rhinitis	0.000624	0.00597	CbGeAlD
Sorafenib—KIT—trachea—allergic rhinitis	0.000619	0.00592	CbGeAlD
Sorafenib—PDGFRB—trachea—allergic rhinitis	0.000605	0.00578	CbGeAlD
Sorafenib—FLT1—lung—allergic rhinitis	0.000594	0.00568	CbGeAlD
Sorafenib—RAF1—lung—allergic rhinitis	0.00059	0.00565	CbGeAlD
Sorafenib—EPHB6—lung—allergic rhinitis	0.000587	0.00561	CbGeAlD
Sorafenib—STK10—lung—allergic rhinitis	0.000562	0.00538	CbGeAlD
Sorafenib—PDGFRA—lung—allergic rhinitis	0.000556	0.00532	CbGeAlD
Sorafenib—ABCC4—bronchus—allergic rhinitis	0.000536	0.00513	CbGeAlD
Sorafenib—HTR2B—skin of body—allergic rhinitis	0.000515	0.00493	CbGeAlD
Sorafenib—MAP2K5—lung—allergic rhinitis	0.000502	0.0048	CbGeAlD
Sorafenib—KDR—lung—allergic rhinitis	0.000502	0.0048	CbGeAlD
Sorafenib—CSF1R—lung—allergic rhinitis	0.00049	0.00469	CbGeAlD
Sorafenib—KIT—lung—allergic rhinitis	0.000445	0.00425	CbGeAlD
Sorafenib—CYP1A2—respiratory system—allergic rhinitis	0.000443	0.00423	CbGeAlD
Sorafenib—PDGFRB—lung—allergic rhinitis	0.000435	0.00416	CbGeAlD
Sorafenib—CYP3A5—respiratory system—allergic rhinitis	0.000427	0.00408	CbGeAlD
Sorafenib—CYP2B6—respiratory system—allergic rhinitis	0.000424	0.00406	CbGeAlD
Sorafenib—CYP2B6—bronchus—allergic rhinitis	0.000349	0.00334	CbGeAlD
Sorafenib—ABCC4—lung—allergic rhinitis	0.000346	0.00331	CbGeAlD
Sorafenib—HTR2B—lung—allergic rhinitis	0.000344	0.00329	CbGeAlD
Sorafenib—CYP2B6—skin of body—allergic rhinitis	0.000337	0.00323	CbGeAlD
Sorafenib—ABCG2—lung—allergic rhinitis	0.000244	0.00234	CbGeAlD
Sorafenib—CYP1A2—lung—allergic rhinitis	0.000235	0.00225	CbGeAlD
Sorafenib—ABCB1—respiratory system—allergic rhinitis	0.000227	0.00217	CbGeAlD
Sorafenib—CYP3A5—lung—allergic rhinitis	0.000227	0.00217	CbGeAlD
Sorafenib—CYP2B6—lung—allergic rhinitis	0.000225	0.00215	CbGeAlD
Sorafenib—ABCB1—epithelium—allergic rhinitis	0.00019	0.00181	CbGeAlD
Sorafenib—Gastrointestinal pain—Montelukast—allergic rhinitis	0.000188	0.00101	CcSEcCtD
Sorafenib—Diarrhoea—Cetirizine—allergic rhinitis	0.000188	0.00101	CcSEcCtD
Sorafenib—Vomiting—Loratadine—allergic rhinitis	0.000185	0.000995	CcSEcCtD
Sorafenib—Diarrhoea—Flunisolide—allergic rhinitis	0.000185	0.000991	CcSEcCtD
Sorafenib—Rash—Loratadine—allergic rhinitis	0.000184	0.000987	CcSEcCtD
Sorafenib—Dermatitis—Loratadine—allergic rhinitis	0.000184	0.000986	CcSEcCtD
Sorafenib—Infestation—Methylprednisolone—allergic rhinitis	0.000183	0.000982	CcSEcCtD
Sorafenib—Infestation NOS—Methylprednisolone—allergic rhinitis	0.000183	0.000982	CcSEcCtD
Sorafenib—Urticaria—Montelukast—allergic rhinitis	0.000183	0.000981	CcSEcCtD
Sorafenib—Headache—Loratadine—allergic rhinitis	0.000183	0.000981	CcSEcCtD
Sorafenib—Abdominal pain—Montelukast—allergic rhinitis	0.000182	0.000976	CcSEcCtD
Sorafenib—Body temperature increased—Montelukast—allergic rhinitis	0.000182	0.000976	CcSEcCtD
Sorafenib—Dizziness—Cetirizine—allergic rhinitis	0.000181	0.000974	CcSEcCtD
Sorafenib—Acute coronary syndrome—Triamcinolone—allergic rhinitis	0.000181	0.000971	CcSEcCtD
Sorafenib—Acute coronary syndrome—Methylprednisolone—allergic rhinitis	0.00018	0.000968	CcSEcCtD
Sorafenib—Haemoglobin—Prednisolone—allergic rhinitis	0.00018	0.000966	CcSEcCtD
Sorafenib—Neuropathy peripheral—Triamcinolone—allergic rhinitis	0.00018	0.000965	CcSEcCtD
Sorafenib—Myocardial infarction—Triamcinolone—allergic rhinitis	0.00018	0.000965	CcSEcCtD
Sorafenib—Neuropathy peripheral—Methylprednisolone—allergic rhinitis	0.000179	0.000963	CcSEcCtD
Sorafenib—Myocardial infarction—Methylprednisolone—allergic rhinitis	0.000179	0.000963	CcSEcCtD
Sorafenib—Haemorrhage—Prednisolone—allergic rhinitis	0.000179	0.000961	CcSEcCtD
Sorafenib—Dizziness—Flunisolide—allergic rhinitis	0.000178	0.000958	CcSEcCtD
Sorafenib—Haemoglobin—Hydrocortisone—allergic rhinitis	0.000176	0.000944	CcSEcCtD
Sorafenib—Haemorrhage—Hydrocortisone—allergic rhinitis	0.000175	0.000939	CcSEcCtD
Sorafenib—Vomiting—Cetirizine—allergic rhinitis	0.000174	0.000936	CcSEcCtD
Sorafenib—Nausea—Loratadine—allergic rhinitis	0.000173	0.00093	CcSEcCtD
Sorafenib—Epistaxis—Triamcinolone—allergic rhinitis	0.000173	0.000929	CcSEcCtD
Sorafenib—Rash—Cetirizine—allergic rhinitis	0.000173	0.000929	CcSEcCtD
Sorafenib—Dermatitis—Cetirizine—allergic rhinitis	0.000173	0.000928	CcSEcCtD
Sorafenib—Headache—Cetirizine—allergic rhinitis	0.000172	0.000923	CcSEcCtD
Sorafenib—Connective tissue disorder—Hydrocortisone—allergic rhinitis	0.000172	0.000922	CcSEcCtD
Sorafenib—Vomiting—Flunisolide—allergic rhinitis	0.000172	0.000921	CcSEcCtD
Sorafenib—Rash—Flunisolide—allergic rhinitis	0.00017	0.000913	CcSEcCtD
Sorafenib—Dermatitis—Flunisolide—allergic rhinitis	0.00017	0.000912	CcSEcCtD
Sorafenib—Hypersensitivity—Montelukast—allergic rhinitis	0.00017	0.00091	CcSEcCtD
Sorafenib—Headache—Flunisolide—allergic rhinitis	0.000169	0.000907	CcSEcCtD
Sorafenib—Weight decreased—Betamethasone—allergic rhinitis	0.000169	0.000907	CcSEcCtD
Sorafenib—Weight decreased—Dexamethasone—allergic rhinitis	0.000169	0.000907	CcSEcCtD
Sorafenib—ABCB1—trachea—allergic rhinitis	0.000168	0.0016	CbGeAlD
Sorafenib—Haemoglobin—Triamcinolone—allergic rhinitis	0.000165	0.000888	CcSEcCtD
Sorafenib—Haemoglobin—Methylprednisolone—allergic rhinitis	0.000165	0.000886	CcSEcCtD
Sorafenib—Asthenia—Montelukast—allergic rhinitis	0.000165	0.000886	CcSEcCtD
Sorafenib—Haemorrhage—Triamcinolone—allergic rhinitis	0.000165	0.000884	CcSEcCtD
Sorafenib—Haemorrhage—Methylprednisolone—allergic rhinitis	0.000164	0.000882	CcSEcCtD
Sorafenib—Acute coronary syndrome—Betamethasone—allergic rhinitis	0.000164	0.000881	CcSEcCtD
Sorafenib—Acute coronary syndrome—Dexamethasone—allergic rhinitis	0.000164	0.000881	CcSEcCtD
Sorafenib—Neuropathy peripheral—Dexamethasone—allergic rhinitis	0.000163	0.000876	CcSEcCtD
Sorafenib—Neuropathy peripheral—Betamethasone—allergic rhinitis	0.000163	0.000876	CcSEcCtD
Sorafenib—Myocardial infarction—Dexamethasone—allergic rhinitis	0.000163	0.000876	CcSEcCtD
Sorafenib—Myocardial infarction—Betamethasone—allergic rhinitis	0.000163	0.000876	CcSEcCtD
Sorafenib—Nausea—Cetirizine—allergic rhinitis	0.000163	0.000875	CcSEcCtD
Sorafenib—Pruritus—Montelukast—allergic rhinitis	0.000163	0.000874	CcSEcCtD
Sorafenib—Connective tissue disorder—Methylprednisolone—allergic rhinitis	0.000161	0.000867	CcSEcCtD
Sorafenib—Nausea—Flunisolide—allergic rhinitis	0.00016	0.00086	CcSEcCtD
Sorafenib—Arrhythmia—Prednisolone—allergic rhinitis	0.00016	0.000859	CcSEcCtD
Sorafenib—Immune system disorder—Hydrocortisone—allergic rhinitis	0.000158	0.000848	CcSEcCtD
Sorafenib—Diarrhoea—Montelukast—allergic rhinitis	0.000157	0.000845	CcSEcCtD
Sorafenib—Arrhythmia—Hydrocortisone—allergic rhinitis	0.000156	0.000839	CcSEcCtD
Sorafenib—Erythema—Prednisolone—allergic rhinitis	0.000156	0.000837	CcSEcCtD
Sorafenib—Mental disorder—Hydrocortisone—allergic rhinitis	0.000153	0.000822	CcSEcCtD
Sorafenib—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.000152	0.000819	CcSEcCtD
Sorafenib—Erythema—Hydrocortisone—allergic rhinitis	0.000152	0.000817	CcSEcCtD
Sorafenib—Malnutrition—Hydrocortisone—allergic rhinitis	0.000152	0.000817	CcSEcCtD
Sorafenib—Dizziness—Montelukast—allergic rhinitis	0.000152	0.000817	CcSEcCtD
Sorafenib—Haemoglobin—Dexamethasone—allergic rhinitis	0.00015	0.000806	CcSEcCtD
Sorafenib—Haemoglobin—Betamethasone—allergic rhinitis	0.00015	0.000806	CcSEcCtD
Sorafenib—Haemorrhage—Dexamethasone—allergic rhinitis	0.000149	0.000802	CcSEcCtD
Sorafenib—Haemorrhage—Betamethasone—allergic rhinitis	0.000149	0.000802	CcSEcCtD
Sorafenib—Angiopathy—Methylprednisolone—allergic rhinitis	0.000149	0.0008	CcSEcCtD
Sorafenib—Immune system disorder—Methylprednisolone—allergic rhinitis	0.000148	0.000797	CcSEcCtD
Sorafenib—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000148	0.000795	CcSEcCtD
Sorafenib—Arrhythmia—Triamcinolone—allergic rhinitis	0.000147	0.00079	CcSEcCtD
Sorafenib—Arrhythmia—Methylprednisolone—allergic rhinitis	0.000147	0.000788	CcSEcCtD
Sorafenib—Vomiting—Montelukast—allergic rhinitis	0.000146	0.000785	CcSEcCtD
Sorafenib—Rash—Montelukast—allergic rhinitis	0.000145	0.000779	CcSEcCtD
Sorafenib—Dermatitis—Montelukast—allergic rhinitis	0.000145	0.000778	CcSEcCtD
Sorafenib—Headache—Montelukast—allergic rhinitis	0.000144	0.000774	CcSEcCtD
Sorafenib—Mental disorder—Methylprednisolone—allergic rhinitis	0.000144	0.000773	CcSEcCtD
Sorafenib—Erythema—Triamcinolone—allergic rhinitis	0.000143	0.000769	CcSEcCtD
Sorafenib—Erythema—Methylprednisolone—allergic rhinitis	0.000143	0.000768	CcSEcCtD
Sorafenib—Malnutrition—Methylprednisolone—allergic rhinitis	0.000143	0.000768	CcSEcCtD
Sorafenib—Angioedema—Prednisolone—allergic rhinitis	0.000142	0.000765	CcSEcCtD
Sorafenib—Dysgeusia—Triamcinolone—allergic rhinitis	0.00014	0.000754	CcSEcCtD
Sorafenib—Syncope—Prednisolone—allergic rhinitis	0.00014	0.00075	CcSEcCtD
Sorafenib—Angioedema—Hydrocortisone—allergic rhinitis	0.000139	0.000747	CcSEcCtD
Sorafenib—Loss of consciousness—Prednisolone—allergic rhinitis	0.000137	0.000735	CcSEcCtD
Sorafenib—Nausea—Montelukast—allergic rhinitis	0.000137	0.000734	CcSEcCtD
Sorafenib—Syncope—Hydrocortisone—allergic rhinitis	0.000137	0.000733	CcSEcCtD
Sorafenib—Angiopathy—Betamethasone—allergic rhinitis	0.000136	0.000728	CcSEcCtD
Sorafenib—Angiopathy—Dexamethasone—allergic rhinitis	0.000136	0.000728	CcSEcCtD
Sorafenib—Hypertension—Prednisolone—allergic rhinitis	0.000135	0.000722	CcSEcCtD
Sorafenib—Loss of consciousness—Hydrocortisone—allergic rhinitis	0.000134	0.000718	CcSEcCtD
Sorafenib—Arrhythmia—Dexamethasone—allergic rhinitis	0.000133	0.000716	CcSEcCtD
Sorafenib—Arrhythmia—Betamethasone—allergic rhinitis	0.000133	0.000716	CcSEcCtD
Sorafenib—Alopecia—Dexamethasone—allergic rhinitis	0.000132	0.000709	CcSEcCtD
Sorafenib—Alopecia—Betamethasone—allergic rhinitis	0.000132	0.000709	CcSEcCtD
Sorafenib—Hypertension—Hydrocortisone—allergic rhinitis	0.000131	0.000706	CcSEcCtD
Sorafenib—Angioedema—Triamcinolone—allergic rhinitis	0.000131	0.000703	CcSEcCtD
Sorafenib—Angioedema—Methylprednisolone—allergic rhinitis	0.000131	0.000702	CcSEcCtD
Sorafenib—Erythema—Betamethasone—allergic rhinitis	0.00013	0.000698	CcSEcCtD
Sorafenib—Erythema—Dexamethasone—allergic rhinitis	0.00013	0.000698	CcSEcCtD
Sorafenib—Myalgia—Hydrocortisone—allergic rhinitis	0.00013	0.000696	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000129	0.000691	CcSEcCtD
Sorafenib—Syncope—Triamcinolone—allergic rhinitis	0.000129	0.00069	CcSEcCtD
Sorafenib—Syncope—Methylprednisolone—allergic rhinitis	0.000128	0.000689	CcSEcCtD
Sorafenib—Anaphylactic shock—Prednisolone—allergic rhinitis	0.000127	0.000683	CcSEcCtD
Sorafenib—Loss of consciousness—Triamcinolone—allergic rhinitis	0.000126	0.000676	CcSEcCtD
Sorafenib—Loss of consciousness—Methylprednisolone—allergic rhinitis	0.000126	0.000675	CcSEcCtD
Sorafenib—Shock—Prednisolone—allergic rhinitis	0.000125	0.000672	CcSEcCtD
Sorafenib—Cough—Triamcinolone—allergic rhinitis	0.000125	0.000671	CcSEcCtD
Sorafenib—Anaphylactic shock—Hydrocortisone—allergic rhinitis	0.000124	0.000667	CcSEcCtD
Sorafenib—Hypertension—Triamcinolone—allergic rhinitis	0.000124	0.000664	CcSEcCtD
Sorafenib—Hypertension—Methylprednisolone—allergic rhinitis	0.000123	0.000663	CcSEcCtD
Sorafenib—Infection—Hydrocortisone—allergic rhinitis	0.000123	0.000663	CcSEcCtD
Sorafenib—Shock—Hydrocortisone—allergic rhinitis	0.000122	0.000656	CcSEcCtD
Sorafenib—Myalgia—Triamcinolone—allergic rhinitis	0.000122	0.000655	CcSEcCtD
Sorafenib—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000122	0.000654	CcSEcCtD
Sorafenib—Arthralgia—Methylprednisolone—allergic rhinitis	0.000122	0.000654	CcSEcCtD
Sorafenib—Myalgia—Methylprednisolone—allergic rhinitis	0.000122	0.000654	CcSEcCtD
Sorafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000121	0.000649	CcSEcCtD
Sorafenib—Skin disorder—Hydrocortisone—allergic rhinitis	0.000121	0.000648	CcSEcCtD
Sorafenib—ABCB1—lung—allergic rhinitis	0.00012	0.00115	CbGeAlD
Sorafenib—Dry mouth—Triamcinolone—allergic rhinitis	0.000119	0.000641	CcSEcCtD
Sorafenib—Angioedema—Dexamethasone—allergic rhinitis	0.000119	0.000638	CcSEcCtD
Sorafenib—Angioedema—Betamethasone—allergic rhinitis	0.000119	0.000638	CcSEcCtD
Sorafenib—Anorexia—Hydrocortisone—allergic rhinitis	0.000118	0.000636	CcSEcCtD
Sorafenib—Anaphylactic shock—Triamcinolone—allergic rhinitis	0.000117	0.000628	CcSEcCtD
Sorafenib—Anaphylactic shock—Methylprednisolone—allergic rhinitis	0.000117	0.000627	CcSEcCtD
Sorafenib—Syncope—Betamethasone—allergic rhinitis	0.000117	0.000626	CcSEcCtD
Sorafenib—Syncope—Dexamethasone—allergic rhinitis	0.000117	0.000626	CcSEcCtD
Sorafenib—Infection—Triamcinolone—allergic rhinitis	0.000116	0.000624	CcSEcCtD
Sorafenib—Infection—Methylprednisolone—allergic rhinitis	0.000116	0.000623	CcSEcCtD
Sorafenib—Shock—Triamcinolone—allergic rhinitis	0.000115	0.000618	CcSEcCtD
Sorafenib—Shock—Methylprednisolone—allergic rhinitis	0.000115	0.000616	CcSEcCtD
Sorafenib—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000114	0.000614	CcSEcCtD
Sorafenib—Loss of consciousness—Dexamethasone—allergic rhinitis	0.000114	0.000614	CcSEcCtD
Sorafenib—Loss of consciousness—Betamethasone—allergic rhinitis	0.000114	0.000614	CcSEcCtD
Sorafenib—Skin disorder—Methylprednisolone—allergic rhinitis	0.000113	0.000609	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	0.000113	0.000608	CcSEcCtD
Sorafenib—Hypertension—Betamethasone—allergic rhinitis	0.000112	0.000603	CcSEcCtD
Sorafenib—Hypertension—Dexamethasone—allergic rhinitis	0.000112	0.000603	CcSEcCtD
Sorafenib—Myalgia—Dexamethasone—allergic rhinitis	0.000111	0.000594	CcSEcCtD
Sorafenib—Myalgia—Betamethasone—allergic rhinitis	0.000111	0.000594	CcSEcCtD
Sorafenib—Dyspepsia—Hydrocortisone—allergic rhinitis	0.000109	0.000587	CcSEcCtD
Sorafenib—Pain—Prednisolone—allergic rhinitis	0.000109	0.000584	CcSEcCtD
Sorafenib—Decreased appetite—Hydrocortisone—allergic rhinitis	0.000108	0.00058	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000107	0.000576	CcSEcCtD
Sorafenib—Fatigue—Hydrocortisone—allergic rhinitis	0.000107	0.000575	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	0.000107	0.000572	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	0.000106	0.000571	CcSEcCtD
Sorafenib—Pain—Hydrocortisone—allergic rhinitis	0.000106	0.00057	CcSEcCtD
Sorafenib—Anaphylactic shock—Betamethasone—allergic rhinitis	0.000106	0.00057	CcSEcCtD
Sorafenib—Anaphylactic shock—Dexamethasone—allergic rhinitis	0.000106	0.00057	CcSEcCtD
Sorafenib—Infection—Betamethasone—allergic rhinitis	0.000105	0.000566	CcSEcCtD
Sorafenib—Infection—Dexamethasone—allergic rhinitis	0.000105	0.000566	CcSEcCtD
Sorafenib—Shock—Betamethasone—allergic rhinitis	0.000104	0.000561	CcSEcCtD
Sorafenib—Shock—Dexamethasone—allergic rhinitis	0.000104	0.000561	CcSEcCtD
Sorafenib—Dyspnoea—Triamcinolone—allergic rhinitis	0.000104	0.00056	CcSEcCtD
Sorafenib—Nervous system disorder—Dexamethasone—allergic rhinitis	0.000104	0.000559	CcSEcCtD
Sorafenib—Nervous system disorder—Betamethasone—allergic rhinitis	0.000104	0.000559	CcSEcCtD
Sorafenib—Thrombocytopenia—Dexamethasone—allergic rhinitis	0.000104	0.000558	CcSEcCtD
Sorafenib—Thrombocytopenia—Betamethasone—allergic rhinitis	0.000104	0.000558	CcSEcCtD
Sorafenib—Dyspepsia—Triamcinolone—allergic rhinitis	0.000103	0.000553	CcSEcCtD
Sorafenib—Dyspepsia—Methylprednisolone—allergic rhinitis	0.000103	0.000552	CcSEcCtD
Sorafenib—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	0.000102	0.000545	CcSEcCtD
Sorafenib—Anorexia—Betamethasone—allergic rhinitis	0.000101	0.000543	CcSEcCtD
Sorafenib—Anorexia—Dexamethasone—allergic rhinitis	0.000101	0.000543	CcSEcCtD
Sorafenib—Urticaria—Prednisolone—allergic rhinitis	0.000101	0.000542	CcSEcCtD
Sorafenib—Fatigue—Triamcinolone—allergic rhinitis	0.000101	0.000541	CcSEcCtD
Sorafenib—Fatigue—Methylprednisolone—allergic rhinitis	0.000101	0.00054	CcSEcCtD
Sorafenib—Pain—Triamcinolone—allergic rhinitis	0.0001	0.000537	CcSEcCtD
Sorafenib—Urticaria—Hydrocortisone—allergic rhinitis	9.87e-05	0.00053	CcSEcCtD
Sorafenib—Abdominal pain—Hydrocortisone—allergic rhinitis	9.82e-05	0.000527	CcSEcCtD
Sorafenib—Body temperature increased—Hydrocortisone—allergic rhinitis	9.82e-05	0.000527	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	9.67e-05	0.000519	CcSEcCtD
Sorafenib—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	9.67e-05	0.000519	CcSEcCtD
Sorafenib—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	9.54e-05	0.000512	CcSEcCtD
Sorafenib—Hypersensitivity—Prednisolone—allergic rhinitis	9.37e-05	0.000503	CcSEcCtD
Sorafenib—Dyspepsia—Dexamethasone—allergic rhinitis	9.34e-05	0.000502	CcSEcCtD
Sorafenib—Dyspepsia—Betamethasone—allergic rhinitis	9.34e-05	0.000502	CcSEcCtD
Sorafenib—Urticaria—Triamcinolone—allergic rhinitis	9.29e-05	0.000499	CcSEcCtD
Sorafenib—Urticaria—Methylprednisolone—allergic rhinitis	9.27e-05	0.000498	CcSEcCtD
Sorafenib—Body temperature increased—Triamcinolone—allergic rhinitis	9.25e-05	0.000496	CcSEcCtD
Sorafenib—Abdominal pain—Methylprednisolone—allergic rhinitis	9.23e-05	0.000495	CcSEcCtD
Sorafenib—Decreased appetite—Dexamethasone—allergic rhinitis	9.23e-05	0.000495	CcSEcCtD
Sorafenib—Decreased appetite—Betamethasone—allergic rhinitis	9.23e-05	0.000495	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Betamethasone—allergic rhinitis	9.16e-05	0.000492	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	9.16e-05	0.000492	CcSEcCtD
Sorafenib—Hypersensitivity—Hydrocortisone—allergic rhinitis	9.15e-05	0.000491	CcSEcCtD
Sorafenib—Fatigue—Betamethasone—allergic rhinitis	9.15e-05	0.000491	CcSEcCtD
Sorafenib—Fatigue—Dexamethasone—allergic rhinitis	9.15e-05	0.000491	CcSEcCtD
Sorafenib—Pain—Betamethasone—allergic rhinitis	9.08e-05	0.000487	CcSEcCtD
Sorafenib—Pain—Dexamethasone—allergic rhinitis	9.08e-05	0.000487	CcSEcCtD
Sorafenib—Asthenia—Hydrocortisone—allergic rhinitis	8.91e-05	0.000479	CcSEcCtD
Sorafenib—Pruritus—Hydrocortisone—allergic rhinitis	8.79e-05	0.000472	CcSEcCtD
Sorafenib—Gastrointestinal pain—Betamethasone—allergic rhinitis	8.68e-05	0.000466	CcSEcCtD
Sorafenib—Gastrointestinal pain—Dexamethasone—allergic rhinitis	8.68e-05	0.000466	CcSEcCtD
Sorafenib—Hypersensitivity—Triamcinolone—allergic rhinitis	8.62e-05	0.000463	CcSEcCtD
Sorafenib—Hypersensitivity—Methylprednisolone—allergic rhinitis	8.6e-05	0.000462	CcSEcCtD
Sorafenib—Diarrhoea—Hydrocortisone—allergic rhinitis	8.5e-05	0.000456	CcSEcCtD
Sorafenib—Urticaria—Dexamethasone—allergic rhinitis	8.43e-05	0.000453	CcSEcCtD
Sorafenib—Urticaria—Betamethasone—allergic rhinitis	8.43e-05	0.000453	CcSEcCtD
Sorafenib—Dizziness—Prednisolone—allergic rhinitis	8.41e-05	0.000452	CcSEcCtD
Sorafenib—Asthenia—Triamcinolone—allergic rhinitis	8.39e-05	0.000451	CcSEcCtD
Sorafenib—Body temperature increased—Betamethasone—allergic rhinitis	8.39e-05	0.00045	CcSEcCtD
Sorafenib—Body temperature increased—Dexamethasone—allergic rhinitis	8.39e-05	0.00045	CcSEcCtD
Sorafenib—Abdominal pain—Dexamethasone—allergic rhinitis	8.39e-05	0.00045	CcSEcCtD
Sorafenib—Abdominal pain—Betamethasone—allergic rhinitis	8.39e-05	0.00045	CcSEcCtD
Sorafenib—Asthenia—Methylprednisolone—allergic rhinitis	8.37e-05	0.00045	CcSEcCtD
Sorafenib—Pruritus—Triamcinolone—allergic rhinitis	8.28e-05	0.000444	CcSEcCtD
Sorafenib—Pruritus—Methylprednisolone—allergic rhinitis	8.26e-05	0.000443	CcSEcCtD
Sorafenib—Dizziness—Hydrocortisone—allergic rhinitis	8.22e-05	0.000441	CcSEcCtD
Sorafenib—Rash—Prednisolone—allergic rhinitis	8.02e-05	0.000431	CcSEcCtD
Sorafenib—Dermatitis—Prednisolone—allergic rhinitis	8.01e-05	0.00043	CcSEcCtD
Sorafenib—Diarrhoea—Methylprednisolone—allergic rhinitis	7.99e-05	0.000429	CcSEcCtD
Sorafenib—Headache—Prednisolone—allergic rhinitis	7.97e-05	0.000428	CcSEcCtD
Sorafenib—Vomiting—Hydrocortisone—allergic rhinitis	7.9e-05	0.000424	CcSEcCtD
Sorafenib—Rash—Hydrocortisone—allergic rhinitis	7.83e-05	0.000421	CcSEcCtD
Sorafenib—Dermatitis—Hydrocortisone—allergic rhinitis	7.83e-05	0.00042	CcSEcCtD
Sorafenib—Headache—Hydrocortisone—allergic rhinitis	7.78e-05	0.000418	CcSEcCtD
Sorafenib—Dizziness—Triamcinolone—allergic rhinitis	7.74e-05	0.000415	CcSEcCtD
Sorafenib—Dizziness—Methylprednisolone—allergic rhinitis	7.72e-05	0.000414	CcSEcCtD
Sorafenib—Asthenia—Dexamethasone—allergic rhinitis	7.62e-05	0.000409	CcSEcCtD
Sorafenib—Asthenia—Betamethasone—allergic rhinitis	7.62e-05	0.000409	CcSEcCtD
Sorafenib—Nausea—Prednisolone—allergic rhinitis	7.56e-05	0.000406	CcSEcCtD
Sorafenib—Pruritus—Betamethasone—allergic rhinitis	7.51e-05	0.000403	CcSEcCtD
Sorafenib—Pruritus—Dexamethasone—allergic rhinitis	7.51e-05	0.000403	CcSEcCtD
Sorafenib—Vomiting—Triamcinolone—allergic rhinitis	7.44e-05	0.000399	CcSEcCtD
Sorafenib—Vomiting—Methylprednisolone—allergic rhinitis	7.42e-05	0.000398	CcSEcCtD
Sorafenib—Nausea—Hydrocortisone—allergic rhinitis	7.38e-05	0.000396	CcSEcCtD
Sorafenib—Rash—Triamcinolone—allergic rhinitis	7.38e-05	0.000396	CcSEcCtD
Sorafenib—Dermatitis—Triamcinolone—allergic rhinitis	7.37e-05	0.000396	CcSEcCtD
Sorafenib—Rash—Methylprednisolone—allergic rhinitis	7.36e-05	0.000395	CcSEcCtD
Sorafenib—Dermatitis—Methylprednisolone—allergic rhinitis	7.35e-05	0.000395	CcSEcCtD
Sorafenib—Headache—Triamcinolone—allergic rhinitis	7.33e-05	0.000393	CcSEcCtD
Sorafenib—Headache—Methylprednisolone—allergic rhinitis	7.31e-05	0.000393	CcSEcCtD
Sorafenib—Diarrhoea—Betamethasone—allergic rhinitis	7.26e-05	0.00039	CcSEcCtD
Sorafenib—Diarrhoea—Dexamethasone—allergic rhinitis	7.26e-05	0.00039	CcSEcCtD
Sorafenib—Dizziness—Betamethasone—allergic rhinitis	7.02e-05	0.000377	CcSEcCtD
Sorafenib—Dizziness—Dexamethasone—allergic rhinitis	7.02e-05	0.000377	CcSEcCtD
Sorafenib—Nausea—Triamcinolone—allergic rhinitis	6.95e-05	0.000373	CcSEcCtD
Sorafenib—Nausea—Methylprednisolone—allergic rhinitis	6.93e-05	0.000372	CcSEcCtD
Sorafenib—Vomiting—Dexamethasone—allergic rhinitis	6.75e-05	0.000362	CcSEcCtD
Sorafenib—Vomiting—Betamethasone—allergic rhinitis	6.75e-05	0.000362	CcSEcCtD
Sorafenib—Rash—Betamethasone—allergic rhinitis	6.69e-05	0.000359	CcSEcCtD
Sorafenib—Rash—Dexamethasone—allergic rhinitis	6.69e-05	0.000359	CcSEcCtD
Sorafenib—Dermatitis—Betamethasone—allergic rhinitis	6.69e-05	0.000359	CcSEcCtD
Sorafenib—Dermatitis—Dexamethasone—allergic rhinitis	6.69e-05	0.000359	CcSEcCtD
Sorafenib—Headache—Dexamethasone—allergic rhinitis	6.65e-05	0.000357	CcSEcCtD
Sorafenib—Headache—Betamethasone—allergic rhinitis	6.65e-05	0.000357	CcSEcCtD
Sorafenib—Nausea—Betamethasone—allergic rhinitis	6.3e-05	0.000338	CcSEcCtD
Sorafenib—Nausea—Dexamethasone—allergic rhinitis	6.3e-05	0.000338	CcSEcCtD
Sorafenib—RAF1—Signaling by GPCR—CCL11—allergic rhinitis	4.31e-05	0.000693	CbGpPWpGaD
Sorafenib—EPHB6—Developmental Biology—TGFB1—allergic rhinitis	4.29e-05	0.000688	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—CYSLTR1—allergic rhinitis	4.25e-05	0.000682	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—HLA-DQB1—allergic rhinitis	4.24e-05	0.000682	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—HLA-DQB1—allergic rhinitis	4.23e-05	0.00068	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—SMAD3—allergic rhinitis	4.21e-05	0.000676	CbGpPWpGaD
Sorafenib—RAF1—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	4.21e-05	0.000676	CbGpPWpGaD
Sorafenib—UGT1A1—NRF2 pathway—TGFB1—allergic rhinitis	4.21e-05	0.000676	CbGpPWpGaD
Sorafenib—UGT1A9—NRF2 pathway—TGFB1—allergic rhinitis	4.21e-05	0.000676	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—PTGDR2—allergic rhinitis	4.2e-05	0.000675	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—PTGDR2—allergic rhinitis	4.19e-05	0.000673	CbGpPWpGaD
Sorafenib—MAPK11—Signaling by NGF—NFKB1—allergic rhinitis	4.18e-05	0.000672	CbGpPWpGaD
Sorafenib—BRAF—Signaling by NGF—NFKB1—allergic rhinitis	4.15e-05	0.000666	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—SMAD3—allergic rhinitis	4.14e-05	0.000665	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—HLA-G—allergic rhinitis	4.12e-05	0.000663	CbGpPWpGaD
Sorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	4.12e-05	0.000662	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—HLA-G—allergic rhinitis	4.11e-05	0.000661	CbGpPWpGaD
Sorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	4.11e-05	0.00066	CbGpPWpGaD
Sorafenib—ABCC2—NRF2 pathway—TGFB1—allergic rhinitis	4.1e-05	0.000659	CbGpPWpGaD
Sorafenib—PDGFRB—MAPK Signaling Pathway—TGFB1—allergic rhinitis	4.1e-05	0.000659	CbGpPWpGaD
Sorafenib—EPHA6—Developmental Biology—TGFB1—allergic rhinitis	4.03e-05	0.000647	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	3.96e-05	0.000636	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—IL5—allergic rhinitis	3.89e-05	0.000624	CbGpPWpGaD
Sorafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	3.88e-05	0.000623	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.86e-05	0.00062	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—CYSLTR1—allergic rhinitis	3.85e-05	0.000619	CbGpPWpGaD
Sorafenib—MAP3K7—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	3.84e-05	0.000616	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—CYSLTR1—allergic rhinitis	3.81e-05	0.000613	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—HLA-DQB1—allergic rhinitis	3.81e-05	0.000613	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—PTGDR2—allergic rhinitis	3.77e-05	0.000606	CbGpPWpGaD
Sorafenib—KIT—Signaling by NGF—NFKB1—allergic rhinitis	3.77e-05	0.000606	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—CCL11—allergic rhinitis	3.72e-05	0.000598	CbGpPWpGaD
Sorafenib—CDK7—Gene Expression—SMAD3—allergic rhinitis	3.72e-05	0.000597	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—CCL11—allergic rhinitis	3.72e-05	0.000597	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—HLA-G—allergic rhinitis	3.71e-05	0.000595	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—TAC1—allergic rhinitis	3.69e-05	0.000593	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—CCL11—allergic rhinitis	3.68e-05	0.000592	CbGpPWpGaD
Sorafenib—RAF1—MAPK Signaling Pathway—TGFB1—allergic rhinitis	3.66e-05	0.000587	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—SMAD3—allergic rhinitis	3.64e-05	0.000585	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—PTGDR2—allergic rhinitis	3.6e-05	0.000578	CbGpPWpGaD
Sorafenib—FGFR1—Signaling by NGF—NFKB1—allergic rhinitis	3.58e-05	0.000575	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by NGF—NFKB1—allergic rhinitis	3.57e-05	0.000574	CbGpPWpGaD
Sorafenib—KIT—Immune System—IL5—allergic rhinitis	3.5e-05	0.000563	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—IL5—allergic rhinitis	3.5e-05	0.000563	CbGpPWpGaD
Sorafenib—ABCC4—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	3.49e-05	0.000561	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—CYSLTR1—allergic rhinitis	3.47e-05	0.000558	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—CYSLTR1—allergic rhinitis	3.47e-05	0.000558	CbGpPWpGaD
Sorafenib—CDK7—Disease—SMAD3—allergic rhinitis	3.45e-05	0.000555	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—IL5—allergic rhinitis	3.43e-05	0.000552	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—SMAD3—allergic rhinitis	3.43e-05	0.000551	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—HLA-DQB1—allergic rhinitis	3.4e-05	0.000546	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—PTGDR2—allergic rhinitis	3.36e-05	0.00054	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—TAC1—allergic rhinitis	3.35e-05	0.000539	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—CCL11—allergic rhinitis	3.35e-05	0.000539	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—CCL11—allergic rhinitis	3.35e-05	0.000539	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—IL5—allergic rhinitis	3.32e-05	0.000534	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—IL5—allergic rhinitis	3.32e-05	0.000533	CbGpPWpGaD
Sorafenib—RAF1—Immune System—HLA-G—allergic rhinitis	3.3e-05	0.000531	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	3.3e-05	0.00053	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—CYSLTR1—allergic rhinitis	3.3e-05	0.000529	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—CYSLTR1—allergic rhinitis	3.29e-05	0.000528	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—ICAM1—allergic rhinitis	3.26e-05	0.000524	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—ICAM1—allergic rhinitis	3.26e-05	0.000524	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—TAC1—allergic rhinitis	3.22e-05	0.000518	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by NGF—NFKB1—allergic rhinitis	3.22e-05	0.000517	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—CCL11—allergic rhinitis	3.18e-05	0.000511	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—CCL11—allergic rhinitis	3.17e-05	0.00051	CbGpPWpGaD
Sorafenib—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	3.15e-05	0.000507	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—NFKB1—allergic rhinitis	3.14e-05	0.000505	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—TAC1—allergic rhinitis	3.14e-05	0.000505	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—TAC1—allergic rhinitis	3.13e-05	0.000504	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—IL5—allergic rhinitis	3.12e-05	0.000501	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—ICAM1—allergic rhinitis	3.1e-05	0.000498	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—SMAD3—allergic rhinitis	3.09e-05	0.000496	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—ICAM1—allergic rhinitis	3.09e-05	0.000496	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—HLA-DQB1—allergic rhinitis	3.01e-05	0.000483	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—IL5—allergic rhinitis	3e-05	0.000482	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—IL5—allergic rhinitis	2.99e-05	0.00048	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—TAC1—allergic rhinitis	2.98e-05	0.000479	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—CYSLTR1—allergic rhinitis	2.96e-05	0.000476	CbGpPWpGaD
Sorafenib—RAF1—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	2.94e-05	0.000472	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—IL5—allergic rhinitis	2.92e-05	0.000469	CbGpPWpGaD
Sorafenib—RAF1—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	2.92e-05	0.000469	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—IL5—allergic rhinitis	2.91e-05	0.000468	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—PTGDR2—allergic rhinitis	2.9e-05	0.000466	CbGpPWpGaD
Sorafenib—MKNK1—Disease—CD4—allergic rhinitis	2.89e-05	0.000465	CbGpPWpGaD
Sorafenib—RAF1—Signaling by NGF—NFKB1—allergic rhinitis	2.87e-05	0.000461	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—CCL11—allergic rhinitis	2.86e-05	0.000459	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—CYSLTR1—allergic rhinitis	2.82e-05	0.000454	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—ICAM1—allergic rhinitis	2.78e-05	0.000447	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—IL5—allergic rhinitis	2.77e-05	0.000445	CbGpPWpGaD
Sorafenib—MAPK11—Innate Immune System—CD4—allergic rhinitis	2.77e-05	0.000445	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—CCL11—allergic rhinitis	2.73e-05	0.000438	CbGpPWpGaD
Sorafenib—MAPK11—Gene Expression—SMAD3—allergic rhinitis	2.72e-05	0.000437	CbGpPWpGaD
Sorafenib—KIT—Immune System—HLA-DQB1—allergic rhinitis	2.71e-05	0.000436	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—HLA-DQB1—allergic rhinitis	2.71e-05	0.000436	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—TAC1—allergic rhinitis	2.71e-05	0.000435	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—NFKB1—allergic rhinitis	2.7e-05	0.000434	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—TAC1—allergic rhinitis	2.7e-05	0.000434	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—TAC1—allergic rhinitis	2.68e-05	0.00043	CbGpPWpGaD
Sorafenib—RAF1—Immune System—IL5—allergic rhinitis	2.66e-05	0.000428	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—CYSLTR1—allergic rhinitis	2.64e-05	0.000424	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—TGFB1—allergic rhinitis	2.62e-05	0.000421	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—HLA-DQB1—allergic rhinitis	2.57e-05	0.000414	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—HLA-DQB1—allergic rhinitis	2.57e-05	0.000412	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—CCL11—allergic rhinitis	2.55e-05	0.000409	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—IL5—allergic rhinitis	2.52e-05	0.000404	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—IL5—allergic rhinitis	2.51e-05	0.000404	CbGpPWpGaD
Sorafenib—BRAF—Disease—SMAD3—allergic rhinitis	2.5e-05	0.000402	CbGpPWpGaD
Sorafenib—KIT—Innate Immune System—CD4—allergic rhinitis	2.5e-05	0.000401	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—CD4—allergic rhinitis	2.5e-05	0.000401	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—IL5—allergic rhinitis	2.49e-05	0.0004	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—ICAM1—allergic rhinitis	2.48e-05	0.000399	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—TAC1—allergic rhinitis	2.44e-05	0.000391	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—TAC1—allergic rhinitis	2.44e-05	0.000391	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—CD4—allergic rhinitis	2.4e-05	0.000385	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—CD4—allergic rhinitis	2.4e-05	0.000385	CbGpPWpGaD
Sorafenib—MAPK11—Innate Immune System—NFKB1—allergic rhinitis	2.39e-05	0.000383	CbGpPWpGaD
Sorafenib—FGFR1—Innate Immune System—CD4—allergic rhinitis	2.37e-05	0.000381	CbGpPWpGaD
Sorafenib—PDGFRA—Innate Immune System—CD4—allergic rhinitis	2.36e-05	0.00038	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—HLA-DQB1—allergic rhinitis	2.31e-05	0.000372	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—NFKB1—allergic rhinitis	2.31e-05	0.000371	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—TAC1—allergic rhinitis	2.31e-05	0.000371	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—TAC1—allergic rhinitis	2.31e-05	0.000371	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—CYSLTR1—allergic rhinitis	2.28e-05	0.000366	CbGpPWpGaD
Sorafenib—KIT—Disease—SMAD3—allergic rhinitis	2.28e-05	0.000366	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—CD4—allergic rhinitis	2.28e-05	0.000366	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—CD4—allergic rhinitis	2.27e-05	0.000365	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—IL5—allergic rhinitis	2.27e-05	0.000364	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—IL5—allergic rhinitis	2.27e-05	0.000364	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—TGFB1—allergic rhinitis	2.25e-05	0.000362	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—CCL11—allergic rhinitis	2.2e-05	0.000353	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—ICAM1—allergic rhinitis	2.2e-05	0.000353	CbGpPWpGaD
Sorafenib—FGFR1—Disease—SMAD3—allergic rhinitis	2.16e-05	0.000347	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—SMAD3—allergic rhinitis	2.16e-05	0.000346	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—NFKB1—allergic rhinitis	2.15e-05	0.000346	CbGpPWpGaD
Sorafenib—KIT—Innate Immune System—NFKB1—allergic rhinitis	2.15e-05	0.000346	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—IL5—allergic rhinitis	2.15e-05	0.000345	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—IL5—allergic rhinitis	2.14e-05	0.000344	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—NFKB1—allergic rhinitis	2.14e-05	0.000344	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—CD4—allergic rhinitis	2.13e-05	0.000342	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—SMAD3—allergic rhinitis	2.11e-05	0.000339	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—NFKB1—allergic rhinitis	2.11e-05	0.000338	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—TAC1—allergic rhinitis	2.08e-05	0.000334	CbGpPWpGaD
Sorafenib—MKNK1—Disease—TGFB1—allergic rhinitis	2.08e-05	0.000333	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—NFKB1—allergic rhinitis	2.07e-05	0.000332	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—NFKB1—allergic rhinitis	2.07e-05	0.000332	CbGpPWpGaD
Sorafenib—RAF1—Immune System—HLA-DQB1—allergic rhinitis	2.06e-05	0.000331	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—SMAD3—allergic rhinitis	2.06e-05	0.00033	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—CD4—allergic rhinitis	2.05e-05	0.000329	CbGpPWpGaD
Sorafenib—FGFR1—Innate Immune System—NFKB1—allergic rhinitis	2.04e-05	0.000328	CbGpPWpGaD
Sorafenib—CDK7—Disease—CD4—allergic rhinitis	2.04e-05	0.000327	CbGpPWpGaD
Sorafenib—PDGFRA—Innate Immune System—NFKB1—allergic rhinitis	2.04e-05	0.000327	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—TAC1—allergic rhinitis	1.98e-05	0.000318	CbGpPWpGaD
Sorafenib—KIT—Immune System—ICAM1—allergic rhinitis	1.98e-05	0.000318	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—ICAM1—allergic rhinitis	1.98e-05	0.000318	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—NFKB1—allergic rhinitis	1.96e-05	0.000315	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—NFKB1—allergic rhinitis	1.96e-05	0.000314	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—SMAD3—allergic rhinitis	1.94e-05	0.000312	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—IL5—allergic rhinitis	1.93e-05	0.00031	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—TGFB1—allergic rhinitis	1.93e-05	0.000309	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—CD4—allergic rhinitis	1.9e-05	0.000305	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—ICAM1—allergic rhinitis	1.88e-05	0.000302	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—ICAM1—allergic rhinitis	1.87e-05	0.000301	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	1.87e-05	0.0003	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—NFKB1—allergic rhinitis	1.85e-05	0.000298	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TAC1—allergic rhinitis	1.85e-05	0.000298	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—IL5—allergic rhinitis	1.84e-05	0.000296	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—NFKB1—allergic rhinitis	1.84e-05	0.000295	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—CD4—allergic rhinitis	1.82e-05	0.000293	CbGpPWpGaD
Sorafenib—ABCC4—Hemostasis—TGFB1—allergic rhinitis	1.8e-05	0.000289	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—TGFB1—allergic rhinitis	1.78e-05	0.000286	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—SMAD3—allergic rhinitis	1.77e-05	0.000284	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—NFKB1—allergic rhinitis	1.76e-05	0.000283	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—TGFB1—allergic rhinitis	1.75e-05	0.000282	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—SMAD3—allergic rhinitis	1.75e-05	0.000281	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—NFKB1—allergic rhinitis	1.74e-05	0.00028	CbGpPWpGaD
Sorafenib—RAF1—Disease—SMAD3—allergic rhinitis	1.73e-05	0.000278	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—IL5—allergic rhinitis	1.72e-05	0.000277	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—ICAM1—allergic rhinitis	1.69e-05	0.000271	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—NFKB1—allergic rhinitis	1.64e-05	0.000263	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—CD4—allergic rhinitis	1.61e-05	0.000259	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TAC1—allergic rhinitis	1.6e-05	0.000257	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—SMAD3—allergic rhinitis	1.59e-05	0.000256	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—SMAD3—allergic rhinitis	1.59e-05	0.000256	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—NFKB1—allergic rhinitis	1.57e-05	0.000252	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—NFKB1—allergic rhinitis	1.57e-05	0.000252	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	1.56e-05	0.00025	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—TGFB1—allergic rhinitis	1.54e-05	0.000248	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—TGFB1—allergic rhinitis	1.51e-05	0.000243	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—SMAD3—allergic rhinitis	1.51e-05	0.000243	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—SMAD3—allergic rhinitis	1.51e-05	0.000242	CbGpPWpGaD
Sorafenib—RAF1—Immune System—ICAM1—allergic rhinitis	1.5e-05	0.000242	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—IL5—allergic rhinitis	1.49e-05	0.000239	CbGpPWpGaD
Sorafenib—BRAF—Disease—CD4—allergic rhinitis	1.48e-05	0.000237	CbGpPWpGaD
Sorafenib—CDK7—Disease—TGFB1—allergic rhinitis	1.46e-05	0.000235	CbGpPWpGaD
Sorafenib—KIT—Immune System—CD4—allergic rhinitis	1.45e-05	0.000234	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—CD4—allergic rhinitis	1.45e-05	0.000234	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—TGFB1—allergic rhinitis	1.45e-05	0.000233	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—NFKB1—allergic rhinitis	1.39e-05	0.000223	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—CD4—allergic rhinitis	1.38e-05	0.000222	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—CD4—allergic rhinitis	1.38e-05	0.000221	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—SMAD3—allergic rhinitis	1.36e-05	0.000218	CbGpPWpGaD
Sorafenib—KIT—Disease—CD4—allergic rhinitis	1.34e-05	0.000216	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—TGFB1—allergic rhinitis	1.31e-05	0.00021	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—SMAD3—allergic rhinitis	1.3e-05	0.000208	CbGpPWpGaD
Sorafenib—FGFR1—Disease—CD4—allergic rhinitis	1.27e-05	0.000205	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—CD4—allergic rhinitis	1.27e-05	0.000204	CbGpPWpGaD
Sorafenib—KIT—Immune System—NFKB1—allergic rhinitis	1.25e-05	0.000201	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—NFKB1—allergic rhinitis	1.25e-05	0.000201	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—CD4—allergic rhinitis	1.24e-05	0.000199	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—SMAD3—allergic rhinitis	1.21e-05	0.000195	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—NFKB1—allergic rhinitis	1.19e-05	0.000191	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—NFKB1—allergic rhinitis	1.19e-05	0.000191	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—CD4—allergic rhinitis	1.15e-05	0.000184	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CD4—allergic rhinitis	1.11e-05	0.000178	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—NFKB1—allergic rhinitis	1.07e-05	0.000172	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—NFKB1—allergic rhinitis	1.07e-05	0.000172	CbGpPWpGaD
Sorafenib—BRAF—Disease—TGFB1—allergic rhinitis	1.06e-05	0.00017	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—SMAD3—allergic rhinitis	1.05e-05	0.000168	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—NFKB1—allergic rhinitis	1.05e-05	0.000168	CbGpPWpGaD
Sorafenib—RAF1—Disease—CD4—allergic rhinitis	1.02e-05	0.000164	CbGpPWpGaD
Sorafenib—KIT—Disease—TGFB1—allergic rhinitis	9.64e-06	0.000155	CbGpPWpGaD
Sorafenib—RAF1—Immune System—NFKB1—allergic rhinitis	9.53e-06	0.000153	CbGpPWpGaD
Sorafenib—FGFR1—Disease—TGFB1—allergic rhinitis	9.15e-06	0.000147	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—TGFB1—allergic rhinitis	9.12e-06	0.000147	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—NFKB1—allergic rhinitis	8.99e-06	0.000144	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—TGFB1—allergic rhinitis	8.93e-06	0.000144	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—NFKB1—allergic rhinitis	8.9e-06	0.000143	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—TGFB1—allergic rhinitis	8.71e-06	0.00014	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—TGFB1—allergic rhinitis	8.22e-06	0.000132	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—NFKB1—allergic rhinitis	8.1e-06	0.00013	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—NFKB1—allergic rhinitis	8.1e-06	0.00013	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—NFKB1—allergic rhinitis	7.69e-06	0.000124	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—NFKB1—allergic rhinitis	7.67e-06	0.000123	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—TGFB1—allergic rhinitis	7.49e-06	0.00012	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—TGFB1—allergic rhinitis	7.42e-06	0.000119	CbGpPWpGaD
Sorafenib—RAF1—Disease—TGFB1—allergic rhinitis	7.33e-06	0.000118	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—NFKB1—allergic rhinitis	6.91e-06	0.000111	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—TGFB1—allergic rhinitis	6.75e-06	0.000108	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—TGFB1—allergic rhinitis	6.75e-06	0.000108	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—NFKB1—allergic rhinitis	6.59e-06	0.000106	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—TGFB1—allergic rhinitis	6.41e-06	0.000103	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—TGFB1—allergic rhinitis	6.39e-06	0.000103	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—NFKB1—allergic rhinitis	6.16e-06	9.9e-05	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—TGFB1—allergic rhinitis	5.76e-06	9.25e-05	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—TGFB1—allergic rhinitis	5.49e-06	8.82e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—NFKB1—allergic rhinitis	5.32e-06	8.54e-05	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—TGFB1—allergic rhinitis	5.13e-06	8.24e-05	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—TGFB1—allergic rhinitis	4.43e-06	7.12e-05	CbGpPWpGaD
